After successfully launching coronavirus vaccine COVISHIELD, the Serum Institute of India (SII) has applied to India’s drugs controller for permission to conduct small domestic trial in India for Novavax’s Coronavirus disease (Covid-19) vaccine candidate 'COVOVAX', SII chief Adar Poonawalla on Saturday said. Novavax, which was found to be 89.3% effective in a UK trial, is the second Covid-19 vaccine that the company will be manufacturing locally.
from IndiaTV India: Google News Feed https://ift.tt/39wsaO3
from IndiaTV India: Google News Feed https://ift.tt/39wsaO3
Comments
Post a Comment